Capacity addition
- Strategic diversification into high-barrier EV battery supply chain (12,000 MTPA battery foil), mitigating exposure to cyclical packaging films.
- Sharp operating recovery underway with Q1 FY27 consolidated PAT surging 75.5% YoY to ₹758.9 Cr and OPM expanding to 24.6%.
- Strong balance sheet resilience (D/E of 0.27, Net Worth ₹12,680 Cr) allows funding the ₹600 Cr project via internal accruals and low-cost debt without dilution.
- Brownfield expansion at existing Jaitpur (MP) site leverages established infrastructure and recently operational aluminium foil manufacturing capabilities.
- Long execution gestation: Phase I commissioning is slated for September 2028 (24 months) and Phase II for September 2030 (48 months), yielding zero near-term revenue impact.
- Demanding OEM qualification hurdles: Battery-grade foils require strict multi-year testing and qualification cycles from EV cell manufacturers before commercial offtake ramps up.
- Persistent global chemical margin pressure driven by Chinese capacity dumping in fluorochemicals and BOPET/BOPP films.
- Large-cap valuation base: At a market cap of ₹68,333 Cr and P/E of 31.6x, multi-fold returns require massive multi-year earnings compounding rather than quick re-rating.
SRF Limited: Capex Evaluation & Multibagger Analysis
Analysis Date: 2026-10-21
Current Price: ₹2,305.0 | Market Cap: ₹68,333 Cr | P/E (TTM): 31.6x | ROCE: 16.0%
1. Ramp-Aware Catalyst Arithmetic
- Announcement: Board approval for a ₹600 Cr capex to establish a 12,000 MTPA battery aluminium foil facility at Jaitpur, Madhya Pradesh via subsidiary SRF Altech Limited.
- Execution Timeline: Split into two phases of ₹300 Cr each:
- Phase I (6,000 MTPA): Commissioning target by September 30, 2028 (~24 months).
- Phase II (6,000 MTPA): Commissioning target by September 30, 2030 (~48 months).
- Revenue Potential at Steady-State:
- Battery-grade foil commands realizations of ₹4,50,000 – ₹5,00,000 per MT.
- Full 12,000 MTPA capacity implies steady-state annual revenue potential of ~₹550–600 Cr.
- TTM Revenue context: ₹17,001 Cr. Thus, the project represents a ~3.2%–3.5% steady-state revenue addition.
- Ramp Schedule:
- Year 1 (FY27) & Year 2 (FY28): 0% uplift (under construction).
- FY29 (Phase I Ramp): ~₹250–300 Cr revenue uplift (~1.5%–1.8%).
- FY31 (Full Steady-State): ~₹570–600 Cr uplift (~3.5%).
- EBITDA & EPS Flow-Through:
- Assuming an operating margin of 22.0% (consistent with company-wide OPM of 22.5%), steady-state EBITDA addition is ~₹125–130 Cr.
- Less depreciation (~₹40 Cr) and interest (~₹15 Cr), PBT adds ~₹70–75 Cr. At a 25% tax rate, net PAT accretion is ~₹55–60 Cr.
- On a base TTM PAT of ₹2,162 Cr, steady-state EPS uplift is ~₹1.9–2.1/share (+2.7% to +3.8% on TTM EPS of ₹72.93).
2. Industry Capital Intensity & Expected CAGR
- Capital Intensity: HIGH. Precision rolling of ultra-thin battery foils (typically sub-12 to 15 microns) requires high-end imported rolling mills and clean-room slitting environments.
- Execution Difficulty: MEDIUM-HIGH. While SRF has operational experience from its recently commissioned general foil line, battery foil involves stringent metallurgy, defect tolerance, and long qualification lead times with battery cell manufacturers (gigafactories).
- Structural CAGR: The EV and battery storage supply chain in India and export markets is expected to grow at >25% CAGR over the next decade. Overall blended specialty chemicals and industrial packaging expect a ~10–12% structural CAGR.
3. Fundamental Quality & Minervini SEPA Assessment
- Earnings Acceleration: SRF is exhibiting a sharp cyclical turnaround. After a trough in FY25 (EPS ₹42.2), FY26 closed at ₹61.91 (+46.7%). Q1 FY27 consolidated net profit jumped 75.5% YoY to ₹758.9 Cr (EPS ₹25.6), and standalone Q2 FY27 PAT rose 20.9% YoY. Fundamental grade is A.
- Balance Sheet Health: Net Debt/Equity is exceptionally conservative at 0.27 (Debt: ₹3,390 Cr vs Net Worth: ₹12,680 Cr). Operating cash flows comfortably support annual capex of ₹2,000+ Cr.
- ROCE: Stood at 16.0% TTM, showing recovery from lower cyclical levels, though still below historical peak levels (>20%).
- Promoter Holding: Completely stable at 50.26% with zero reported pledges or governance overhangs.
4. Valuation Context & Multi-Year Scenarios
- Base Case (+38% Upside over 36 months):
- Specialty fluorochemicals, refrigerants, and agro/pharma intermediates drive 16% CAGR PAT growth to ~₹3,400 Cr by FY29.
- Battery foil Phase I commissions on schedule in late 2028.
- Forward P/E multiple settles at ~27.5x (from trailing 31.6x), yielding an equity valuation of ~₹93,500 Cr (target price ~₹3,180).
- Bull Case (+75% Upside over 36–48 months):
- Rapid ramp-up in fluoropolymer partnership (Chemours), Chinese dumping subsides, and quick vendor qualification in battery foil delivers 22% PAT CAGR to ~₹4,000 Cr.
- P/E expands to 30.0x, valuing the firm at ~₹120,000 Cr (target price ~₹4,030).
- Bear Case (-22% Downside):
- Prolonged Chinese overcapacity in basic refrigerants and packaging films dampens pricing power. Phase I faces delays and extended validation cycles.
- Net profit plateaus near ₹2,200–2,400 Cr and P/E de-rates to 22.0x, yielding a target price around ~₹1,800.
5. Verdict Rationale
- SRF is a high-grade industrial compounder with top-tier technical capability and capital discipline.
- However, from a multibagger hunting perspective, the ₹600 Cr capex is an incremental bolt-on (~3.5% of sales) spread over four years, not a transformational trigger.
- At a large-cap market capitalization of ₹68,333 Cr, a 3x–5x return within an intermediate horizon is structurally constrained by scale. The stock qualifies as POSSIBLE for steady 15–18% annual compounding, but not as an explosive short-to-medium term multibagger.